Pheon Therapeutics Announces $120M Series B Financing To Fund Development Of Its Differentiated ADC Pipeline
Source: menafn.com
Brandon Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brandon Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brandon Capital Today - Breaking & Trending Today
Pheon Therapeutics Raises $120M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...
Source: prnewswire.com
Aravax taps MinterEllison on US$68m Series B raising
The funds will be used to support the development of immunotherapy for peanut allergies
Source: thelawyermag.com
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics
LONDON and SHANGHAI, China, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announce that they have entered into a license agreement under which Myricx will have exclusive
Source: yahoo.com